Published trade mark details for 2597212
This information was published on 2025-10-23T03:15:45 for IP Right Filed Published.
| Field | Value |
| (210) | 2597212 (IR 1882134) |
| (220) |
26 May 2025
|
| (300) |
IL, 06 May 2025, 383423
|
| (500) |
The mark consists of the words "Padagis" above "Naloxone and +.
|
| (511) (510) |
Class 5
Medicinal preparations used as a narcotic antagonist; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations. Class 10 Medical kits consisting of intranasal drug delivery devices, spray pump devices for nasal delivery, and training kits with devices for nasal delivery, sold empty. Class 20 Medicine cabinets. Class 35 Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online pharmacy services. Class 44 Medical and health information services; providing information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips for patients, medical professionals, and pharmacists, via a website; providing pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists, via a website. |
| (540) |
|
| (550) | Figurative |
| (730) |
PADAGIS US LLC
|
Find out more about publications on the About page.